Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-37
Closed -$8.31K 1177
2026
Q1
$8.31K Sell
37
-2
-5% -$498 ﹤0.01% 493
2025
Q4
$9.39K Hold
39
0.01% 413
2025
Q3
$10.7K Hold
39
﹤0.01% 450
2025
Q2
$10.1K Buy
39
+6
+18% +$1.43K ﹤0.01% 442
2025
Q1
$7.39K Hold
33
﹤0.01% 490
2024
Q4
$7.55K Hold
33
﹤0.01% 501
2024
Q3
$8.06K Buy
33
+4
+14% +$894 ﹤0.01% 517
2024
Q2
$6.03K Buy
29
+10
+53% +$2.03K ﹤0.01% 550
2024
Q1
$3.27K Hold
19
﹤0.01% 613
2023
Q4
$3.27K Buy
+19
New +$2.92K ﹤0.01% 613

Other funds holding RMD

Sachetta's RMD Position: Q2 2026 in Review

Sachetta sold out of ResMed (RMD) in Q2 2026, closing a stake of 37 shares — an estimated $8.31K sold.

Sachetta first reported a position in RMD in Q4 2023 and held it in 10 quarters. The position peaked at $10.7K in Q3 2025. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Sachetta reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Sachetta sold 37 ResMed shares in Q2 2026, an estimated $8.31K.
  • Sachetta first reported a position in ResMed in Q4 2023 and held it in 10 quarters.
  • Sachetta's ResMed position peaked at $10.7K in Q3 2025.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.